Closed-blood Sampling Devices in the Adult Critically Ill Patient
Recruiting now · Not applicable
Conditions studied: Acceptability of Health Care
In brief
Based on the hypothesis that the strategy of using Closed-Blood Sampling Devices (CSBD, experimental group) compared to the usual practice (waste discard volume, control group), in critically ill adult patients, will decrease the amount of blood withdrawn for laboratory tests, we want to analyze the number of red blood cells (RBC) administered and arterial catheter-related adverse events (catheter-related bacteremia, catheter obstruction, CBSD malfunction, loss of arterial pressure waveform on the patient's bedside monitor) in both study groups, during ICU stay and up to a maximum of 21 days.
Key facts
- Study ID
- NCT06478160
- Run by
- University of Barcelona
- People needed
- 216
- Starts
- 2024-11-11
- Expected to finish
- 2026-06-07
- Last updated by the study team
- 2025-11-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients with an arterial catheter who agree to participate in the study, with a stay in the ICU of 24h and a minimum of 72h more with an arterial catheter
- Non-inclusion criteria: Therapeutic Limitation of Life Support, Jehovah's Witnesses.
You may not qualify if…
- Patients with chronic renal failure
- Patients with active gastrointestinal bleeding
- Patients diagnosed with hematologic cancer
- Women with menstruation at the time of admission
- Pregnant women
- Withdrawal criteria: presence of active gastrointestinal bleeding during the study inclusion period.
Where it is running
- Hospital Rey Juan Carlos — Madrid, Madrid, Spain (enrolling)
- Hospital Virgen de la Macarena — Seville, Sevilla, Spain (enrolling)
- Hospital Universitario 12 de Octubre — Madrid, Madrid, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.